Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review
暂无分享,去创建一个
D. Manissero | N. Petrosillo | C. Venditti | C. Longshaw | G. Granata | B. Cai | K. Tone | Maria Vittoria Oppia
[1] K. Mertens,et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis , 2019, The Lancet. Infectious diseases.
[2] K. Kaye,et al. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[3] M. Kollef,et al. Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis , 2018, Antimicrobial Agents and Chemotherapy.
[4] O. Cirioni,et al. Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli. , 2017, Diagnostic microbiology and infectious disease.
[5] M. Kollef,et al. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study , 2014, Critical Care.
[6] R. Evans. European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).